Broad benefits When a drug patent expires, other drugmakers quickly roll out generics at a fraction of the price, stopping the inventor from earning monopoly profits but making the medication accessible to almost anyone who needs it
The FDA has approved GLP-1 receptor agonists for type 2 diabetes management, with select agents (semaglutide/Wegovy and liraglutide/Saxenda) also approved for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
In the 1990s fen-phen, a combination drug including fenfluramine and phentermine, was popularized
Infused with a local anesthetic, these innovative treatments are designed to target and eliminate stubborn fat pockets with precision
Many PlexusDx patients report that within the first week of avoiding added sugars, their energy improves and side effects diminish
It influences GLP-1 and GIP receptors, thereby aiding in blood sugar regulation and appetite control